BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37092538)

  • 41. Delineating the genotypic and phenotypic spectrum of
    Acharya A; Kavus H; Dunn P; Nasir A; Folk L; Withrow K; Wentzensen IM; Ruzhnikov MRZ; Fallot C; Smol T; Rama M; Brown K; Whalen S; Ziegler A; Barth M; Chassevent A; Smith-Hicks C; Afenjar A; Courtin T; Heide S; Font-Montgomery E; Heid C; Hamm JA; Love DR; Thabet F; Misra VK; Cunningham M; Leal SM; Jarvela I; Normand EA; Zou F; Helal M; Keren B; Torti E; Chung WK; Schrauwen I
    J Med Genet; 2022 Jul; 59(7):669-677. PubMed ID: 34321324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures.
    Zweier M; Begemann A; McWalter K; Cho MT; Abela L; Banka S; Behring B; Berger A; Brown CW; Carneiro M; Chen J; Cooper GM; ; Finnila CR; Guillen Sacoto MJ; Henderson A; Hüffmeier U; Joset P; Kerr B; Lesca G; Leszinski GS; McDermott JH; Meltzer MR; Monaghan KG; Mostafavi R; Õunap K; Plecko B; Powis Z; Purcarin G; Reimand T; Riedhammer KM; Schreiber JM; Sirsi D; Wierenga KJ; Wojcik MH; Papuc SM; Steindl K; Sticht H; Rauch A
    Eur J Hum Genet; 2019 May; 27(5):747-759. PubMed ID: 30664714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel de novo variant in
    Blackburn PR; Barnett SS; Zimmermann MT; Cousin MA; Kaiwar C; Pinto E Vairo F; Niu Z; Ferber MJ; Urrutia RA; Selcen D; Klee EW; Pichurin PN
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001743. PubMed ID: 28487885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males.
    Kreienkamp HJ; Wagner M; Weigand H; McConkie-Rossell A; McDonald M; Keren B; Mignot C; Gauthier J; Soucy JF; Michaud JL; Dumas M; Smith R; Löbel U; Hempel M; Kubisch C; Denecke J; Campeau PM; Bain JM; Lessel D
    Hum Genet; 2022 Feb; 141(2):257-272. PubMed ID: 34907471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
    Nabais Sá MJ; El Tekle G; de Brouwer APM; Sawyer SL; Del Gaudio D; Parker MJ; Kanani F; van den Boogaard MH; van Gassen K; Van Allen MI; Wierenga K; Purcarin G; Elias ER; Begtrup A; Keller-Ramey J; Bernasocchi T; van de Wiel L; Gilissen C; Venselaar H; Pfundt R; Vissers LELM; Theurillat JP; de Vries BBA
    Am J Hum Genet; 2020 Mar; 106(3):405-411. PubMed ID: 32109420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated with Mild Dysmorphism.
    Zawerton A; Yao B; Yeager JP; Pippucci T; Haseeb A; Smith JD; Wischmann L; Kühl SJ; Dean JCS; Pilz DT; Holder SE; ; ; McNeill A; Graziano C; Lefebvre V
    Am J Hum Genet; 2019 Feb; 104(2):246-259. PubMed ID: 30661772
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Schalk A; Cousin MA; Dsouza NR; Challman TD; Wain KE; Powis Z; Minks K; Trimouille A; Lasseaux E; Lacombe D; Angelini C; Michaud V; Van-Gils J; Spataro N; Ruiz A; Gabau E; Stolerman E; Washington C; Louie R; Lanpher BC; Kemppainen JL; Innes M; Kooy F; Meuwissen M; Goldenberg A; Lecoquierre F; Vera G; Diderich KEM; Sheidley B; El Achkar CM; Park M; Hamdan FF; Michaud JL; Lewis AJ; Zweier C; Reis A; Wagner M; Weigand H; Journel H; Keren B; Passemard S; Mignot C; van Gassen K; Brilstra EH; Itzikowitz G; O'Heir E; Allen J; Donald KA; Korf BR; Skelton T; Thompson M; Robin NH; Rudy NL; Dobyns WB; Foss K; Zarate YA; Bosanko KA; Alembik Y; Durand B; Tran Mau-Them F; Ranza E; Blanc X; Antonarakis SE; McWalter K; Torti E; Millan F; Dameron A; Tokita M; Zimmermann MT; Klee EW; Piton A; Gerard B
    J Med Genet; 2022 Oct; 59(10):965-975. PubMed ID: 34930816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo variants in CNOT3 cause a variable neurodevelopmental disorder.
    Martin R; Splitt M; Genevieve D; Aten E; Collins A; de Bie CI; Faivre L; Foulds N; Giltay J; Ibitoye R; Joss S; Kennedy J; Kerr B; Kivuva E; Koopmans M; Newbury-Ecob R; Jean-Marçais N; Peeters EAJ; Smithson S; Tomkins S; Tranmauthem F; Piton A; van Haeringen A
    Eur J Hum Genet; 2019 Nov; 27(11):1677-1682. PubMed ID: 31201375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
    Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
    Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy.
    O'Donnell-Luria AH; Pais LS; Faundes V; Wood JC; Sveden A; Luria V; Abou Jamra R; Accogli A; Amburgey K; Anderlid BM; Azzarello-Burri S; Basinger AA; Bianchini C; Bird LM; Buchert R; Carre W; Ceulemans S; Charles P; Cox H; Culliton L; Currò A; ; Demurger F; Dowling JJ; Duban-Bedu B; Dubourg C; Eiset SE; Escobar LF; Ferrarini A; Haack TB; Hashim M; Heide S; Helbig KL; Helbig I; Heredia R; Héron D; Isidor B; Jonasson AR; Joset P; Keren B; Kok F; Kroes HY; Lavillaureix A; Lu X; Maas SM; Maegawa GHB; Marcelis CLM; Mark PR; Masruha MR; McLaughlin HM; McWalter K; Melchinger EU; Mercimek-Andrews S; Nava C; Pendziwiat M; Person R; Ramelli GP; Ramos LLP; Rauch A; Reavey C; Renieri A; Rieß A; Sanchez-Valle A; Sattar S; Saunders C; Schwarz N; Smol T; Srour M; Steindl K; Syrbe S; Taylor JC; Telegrafi A; Thiffault I; Trauner DA; van der Linden H; van Koningsbruggen S; Villard L; Vogel I; Vogt J; Weber YG; Wentzensen IM; Widjaja E; Zak J; Baxter S; Banka S; Rodan LH
    Am J Hum Genet; 2019 Jun; 104(6):1210-1222. PubMed ID: 31079897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. De novo DDX3X missense variants in males appear viable and contribute to syndromic intellectual disability.
    Nicola P; Blackburn PR; Rasmussen KJ; Bertsch NL; Klee EW; Hasadsri L; Pichurin PN; Rankin J; Raymond FL; ; Clayton-Smith J
    Am J Med Genet A; 2019 Apr; 179(4):570-578. PubMed ID: 30734472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. De novo missense variants in RAC3 cause a novel neurodevelopmental syndrome.
    Costain G; Callewaert B; Gabriel H; Tan TY; Walker S; Christodoulou J; Lazar T; Menten B; Orkin J; Sadedin S; Snell M; Vanlander A; Vergult S; White SM; Scherer SW; Hayeems RZ; Blaser S; Wodak SJ; Chitayat D; Marshall CR; Meyn MS
    Genet Med; 2019 Apr; 21(4):1021-1026. PubMed ID: 30293988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
    Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
    Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Novel Missense Variant in the Gene
    Yan L; Shen R; Cao Z; Han C; Zhang Y; Liu Y; Yang X; Xie M; Li H
    Biomed Res Int; 2021; 2021():6661860. PubMed ID: 33628804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.
    Gregor A; Sadleir LG; Asadollahi R; Azzarello-Burri S; Battaglia A; Ousager LB; Boonsawat P; Bruel AL; Buchert R; Calpena E; Cogné B; Dallapiccola B; Distelmaier F; Elmslie F; Faivre L; Haack TB; Harrison V; Henderson A; Hunt D; Isidor B; Joset P; Kumada S; Lachmeijer AMA; Lees M; Lynch SA; Martinez F; Matsumoto N; McDougall C; Mefford HC; Miyake N; Myers CT; Moutton S; Nesbitt A; Novelli A; Orellana C; Rauch A; Rosello M; Saida K; Santani AB; Sarkar A; Scheffer IE; Shinawi M; Steindl K; Symonds JD; Zackai EH; ; ; Reis A; Sticht H; Zweier C
    Am J Hum Genet; 2018 Aug; 103(2):305-316. PubMed ID: 30057029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expanding the phenotypic spectrum consequent upon de novo WDR37 missense variants.
    Hay E; Henderson RH; Mansour S; Deshpande C; Jones R; Nutan S; Mankad K; Young RM; Moosajee M; Research Consortium GE; Arno G
    Clin Genet; 2020 Aug; 98(2):191-197. PubMed ID: 32530092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent KCNT2 missense variants affecting p.Arg190 result in a recognizable phenotype.
    Jackson A; Banka S; Stewart H; ; Robinson H; Lovell S; Clayton-Smith J
    Am J Med Genet A; 2021 Oct; 185(10):3083-3091. PubMed ID: 34061450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism.
    Fan Y; Yin W; Hu B; Kline AD; Zhang VW; Liang D; Sun Y; Wang L; Tang S; Powis Z; Li L; Yan H; Shi Z; Yang X; Chen Y; Wang J; Jiang Y; Tan H; Gu X; Wu L; Yu Y
    Am J Hum Genet; 2018 Sep; 103(3):448-455. PubMed ID: 30122539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency.
    Zawerton A; Mignot C; Sigafoos A; Blackburn PR; Haseeb A; McWalter K; Ichikawa S; Nava C; Keren B; Charles P; Marey I; Tabet AC; Levy J; Perrin L; Hartmann A; Lesca G; Schluth-Bolard C; Monin P; Dupuis-Girod S; Guillen Sacoto MJ; Schnur RE; Zhu Z; Poisson A; El Chehadeh S; Alembik Y; Bruel AL; Lehalle D; Nambot S; Moutton S; Odent S; Jaillard S; Dubourg C; Hilhorst-Hofstee Y; Barbaro-Dieber T; Ortega L; Bhoj EJ; Masser-Frye D; Bird LM; Lindstrom K; Ramsey KM; Narayanan V; Fassi E; Willing M; Cole T; Salter CG; Akilapa R; Vandersteen A; Canham N; Rump P; Gerkes EH; Klein Wassink-Ruiter JS; Bijlsma E; Hoffer MJV; Vargas M; Wojcik A; Cherik F; Francannet C; Rosenfeld JA; Machol K; Scott DA; Bacino CA; Wang X; Clark GD; Bertoli M; Zwolinski S; Thomas RH; Akay E; Chang RC; Bressi R; Sanchez Russo R; Srour M; Russell L; Goyette AE; Dupuis L; Mendoza-Londono R; Karimov C; Joseph M; Nizon M; Cogné B; Kuechler A; Piton A; ; Klee EW; Lefebvre V; Clark KJ; Depienne C
    Genet Med; 2020 Mar; 22(3):524-537. PubMed ID: 31578471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.